Moran Michael Shawn Insider Trades

Insider Trading History

Track insider trading activity for Moran Michael Shawn. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Evp, Chief Commercial Officer
Holding Value $16.9k 32,115 shares
Last Trade
Feb 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$493k 10,400 shares
$47.39
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Evp, Chief Commercial Officer
Holding Value $11.4k 21,715 shares
Last Trade
Feb 02, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$33.4k 742 shares
$45.03
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Evp, Chief Commercial Officer
Holding Value $11.8k 22,457 shares
Last Trade
Jan 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.65k 210 shares
$45.94
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Evp, Chief Commercial Officer
Holding Value $11.9k 22,667 shares
Last Trade
Jan 07, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.56k 90 shares
$50.63
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Evp, Chief Commercial Officer
Holding Value $11.9k 22,757 shares
Last Trade
Jan 05, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$76.6k 1,511 shares
$50.69
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Evp, Chief Commercial Officer
Holding Value $12.7k 24,268 shares
Last Trade
Sep 27, 2021 Sale
$4.45M 81,094 shares
$54.88
$0.52

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up